Life science trend tracker #3
An ongoing series about what’s new in life science and how companies can respond.
How can early-stage life science companies reduce risk and speed innovation?
It’s never been more critical for early-stage life science companies to operate with high efficiency and a very clear commercialization pathway.
Essential documents in clinical trials and research
What information should be documented before, during, and after a clinical study?
4 benefits of hybrid clinical trials
Hybrid clinical trials are gaining in popularity. Here’s what you need to know.
Industry leader Q&A: the pre-clinical contracting pathway
What elements of pre-clinical studies could be accelerated by applying insights management technology?
What’s the difference between precision medicine and personalized medicine?
Understanding when to use the terms precision medicine vs personalized medicine.
Can pre-clinical activities be accelerated with insights management tech?
Contracting, study design, and protocols could be candidates for pre-clinical acceleration.
Big vs small pharmaceutical companies driving innovation
How are different pharma organizations approaching innovation?
Top pharmaceutical life cycle management strategies
A pharmaceutical product’s lifecycle can span several decades. How can drug companies maximize a product’s value and maintain market dominance before patent expiry?
Insights management technology is a game-changer for life science teams
A Within3 expert shares how insights management technology supports the drug and device development process and creates opportunities for life science teams.